-+ 0.00%
-+ 0.00%
-+ 0.00%

Greenland Mines biotech unit wins Canada patent for Klotho gene therapy platform targeting Alzheimer’s, aging

PUBT·07/28/2026 13:17:09
Listen to the news
Greenland Mines biotech unit wins Canada patent for Klotho gene therapy platform targeting Alzheimer’s, aging
  • Greenland Mines received a Canadian patent for its Klotho gene therapy platform targeting cognition, memory, Alzheimer’s, aging-related neurodegeneration.
  • Patent No. CA3,005,398 covers use of the secreted Klotho splice variant (s-KL) delivered via a nucleic-acid gene therapy approach.
  • The company said the patent includes 42 granted claims spanning protein expression, delivery methods, and therapeutic use across multiple neurodegenerative indications.
  • KLTO-101, the program covered by the patent, is scheduled to start process development and manufacturing in August 2026.
  • Greenland Mines plans regulatory interactions before end-2026 for KLTO-202, which has reached GMP manufacturing for ALS and other neuromuscular disorders.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Greenland Mines Ltd. published the original content used to generate this news brief on July 28, 2026, and is solely responsible for the information contained therein.